age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
54.59497
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 13,289
| 6,735.8594
| 3,071
| 11
|
white
| 13.298828
| 13
| 0.875
| 0.718994
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.65
|
no dnr
| 5
| 56
| 6.099609
| 145
| 55
| 38.69531
| 140
| 1.799805
| 0.799927
| 1.5
| 143
| 7.449219
| 289
| 39
| 1,340
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 420
| 1
|
45.85397
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 4,246
| 3,055.1699
| 3,030
| 10
|
white
| 21.296875
| 22
| 0.666992
| 0.365967
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
no dnr
| 5
| 45
| 7.699219
| 140
| 5
| 39.29688
| 128
| null | null | 1.099854
| 129
| 7.479492
| 112
| 11
| 4,760
| 0
| 0
| null | 0
| 224
| 1
|
70.06995
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| null | null | 94
| 31,884
| 17,663.625
| 17,761
| 23
|
white
| 22.199219
| 29
| 0.181
| 0.122986
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 93
| 7
| 72
| 24
| 36.19531
| null | 3.399902
| 0.699951
| 4.699219
| 143
| null | 281
| 54
| 1,250
| null | null |
<2 mo. follow-up
| 2.388184
| 4
| 1
|
78.52997
|
male
| 1
| 16
|
Coma
|
Coma
| 2
| 16
|
$11-$25k
| 44
| 295,624
| 174,851
| 163,726
| 43.666657
|
white
| 29
| 58
| 0.097992
| 0.058998
| 67
| 0
| 0
|
no
| 0.3
| 0.027
|
dnr after sadm
| 12
| 133
| 0.099991
| 110
| 43
| 36
| 116.3125
| null | 20.5
| 1.299805
| 152
| 7.459961
| 231
| 51
| 3,460
| null | 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
43.95599
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 22,270
| 14,354.4141
| 18,046
| 21
|
black
| 19.699219
| 27
| 0.903931
| 0.869995
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 150
| 7.899414
| 105
| 34
| 36.29688
| 260
| 2.899902
| 1.099854
| 2.299805
| 142
| 7.369141
| 98
| 58
| 1,490
| 1
| 0
| null | 0
| 814
| 0
|
47.85797
|
male
| 0
| 19
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 10
| null | 0
| 29,024
| 17,875.7656
| 21,016
| 11
|
white
| 18
| 14
| 0.870972
| 0.785889
| 1
| 1
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 19
| 62
| 9.298828
| 140
| 20
| 35
| 237.125
| 2.5
| 4
| 3
| 142
| 7.509766
| 104
| 67
| 3,400
| 2
| 1
|
no(M2 and SIP pres)
| 1
| 815
| 0
|
46.155
|
male
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 115,662
| 66,758.75
| 65,619
| 30.666656
|
white
| 21
| 37
| 0.85498
| 0.804932
| 11
| 0
| 0
|
no
| 0.95
| 0.94
|
no dnr
| 20
| 58
| 11.298828
| 115
| 41
| 36.69531
| 63
| null | 14.398438
| 2.399902
| 150
| 7.339844
| 90
| 10
| 355
| null | 3
|
no(M2 and SIP pres)
| 3
| 815
| 0
|
45.60999
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 20,191
| 12,313.1172
| 13,961
| 15
|
hispanic
| 17.097656
| 27
| 0.942993
| 0.902954
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 13
| 48
| 14.398438
| 105
| 11
| 38.39844
| 184.4375
| null | null | 2.099609
| 137
| 7.439453
| 150
| 51
| 2,640
| 1
| 1
| null | 1
| 814
| 0
|
66.95099
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 61
| 107,918
| 56,022.4062
| 59,728
| 52
|
white
| 46.09375
| 80
| 0.011999
| 0.002
| 16
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 100
| 14.898438
| 125
| 14
| 38.79688
| 376.625
| null | null | 1
| 137
| 7.419922
| 244
| 19
| 2,235
| null | null |
<2 mo. follow-up
| 2.954102
| 5
| 1
|
68.26599
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 8,255
| 6,076.8086
| 6,907
| 7.5
|
white
| 25
| 28
| 0.635986
| 0.453979
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 10
| 78
| 4.199219
| 120
| 10
| 35.59375
| null | null | 0.899902
| 3.699707
| 126
| null | 180
| 83
| 4,035
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 117
| 1
|
50.46698
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
$11-$25k
| 0
| 55,520
| 34,977
| 38,101
| 13.333328
|
black
| 22.097656
| 26
| 0.840942
| 0.786987
| 6
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 19
| 108
| 5.699219
| 80
| 20
| 36.09375
| 185.6875
| 3.399902
| 0.5
| 3
| 136
| 7.399414
| 130
| 47
| 4,500
| null | 0
|
no(M2 and SIP pres)
| 0
| 812
| 0
|
65.79596
|
female
| 1
| 11
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 10,715
| 7,155.7812
| 7,148
| 9.5
|
white
| 33.796875
| 31
| 0.255981
| 0.033997
| 1
| 1
| 0
|
metastatic
| 0.4
| 0.2
|
dnr after sadm
| 10
| 112
| 1.699951
| 65
| 26
| 36.59375
| 283.3125
| null | 1.399902
| 0.599976
| 146
| 7.449219
| 93
| 21
| 3,720
| 4
| 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
70.25098
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
| null | 9
| 68,825
| 38,212.2188
| 37,550
| 16
|
black
| 21.699219
| 22
| 0.79895
| 0.73291
| 1
| 1
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 16
| 103
| 16
| 102
| 24
| 36.79688
| 159.15625
| null | 1
| 0.699951
| 145
| 7.329102
| 237
| 6
| 950
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 262
| 1
|
56.76398
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$25-$50k
| 0
| 68,058
| 39,405.25
| 37,896
| 16.666656
|
white
| 24.898438
| 25
| 0.726929
| 0.642944
| 7
| 0
| 0
|
yes
| 0.99
| 0.970299
|
no dnr
| 17
| 65
| 7.699219
| 55
| 20
| 36.39844
| null | null | 0.5
| 1.199951
| 136
| null | 80
| 26
| 950
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 810
| 0
|
59.35397
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
$25-$50k
| 0
| 2,370
| 1,662.3418
| 1,842
| 8
|
white
| 9.599609
| 18
| 0.949951
| 0.91394
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 3
| 112
| 15.798828
| 130
| 24
| 36.29688
| 87.6875
| 2.899902
| 3.399902
| 1.199951
| 140
| 7.40918
| 202
| 72
| 3,320
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 315
| 1
|
52.465
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 109,993
| 64,156.375
| 64,956
| 39.666657
|
white
| 31.796875
| 54
| 0.672974
| 0.576904
| 6
| 1
| 0
|
no
| null | null |
no dnr
| 22
| 115
| 13.099609
| 120
| 24
| 36.5
| 300
| 3.699707
| 0.799927
| 1
| 138
| 7.30957
| 132
| 14
| 900
| null | 1
|
no(M2 and SIP pres)
| 1
| 809
| 0
|
61.41498
|
male
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 316,205
| 172,765.625
| 148,295
| 45
|
white
| 33.898438
| 54
| 0.473999
| 0.35498
| 9
| 0
| 0
|
yes
| 0.5
| 0.5
|
dnr after sadm
| 40
| 64
| 15.5
| 98
| 20
| 35.19531
| 480.9375
| 2.299805
| 7.399414
| 2.299805
| 135
| 7.509766
| 114
| 74
| 305
| null | 0
|
<2 mo. follow-up
| 0
| 43
| 1
|
62.35999
|
female
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
under $11k
| 0
| 64,166
| 38,736.25
| 39,179
| 29.333328
|
white
| 17.199219
| 38
| 0.861938
| 0.813965
| 1
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 10
| 101
| 16.898438
| 65
| 14
| 36.5
| 304.75
| null | 0.599976
| 2
| 130
| 7.469727
| 177
| 58
| 3,135
| null | null |
<2 mo. follow-up
| 1.850586
| 15
| 1
|
84.07898
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 76,664
| null | null | 33
|
white
| 21.296875
| 35
| 0.715942
| 0.628906
| 11
| 0
| 0
|
no
| 0.5
| 0.45
|
dnr after sadm
| 2
| 98
| 7.299805
| 72
| 16
| 36.39844
| null | 4.5
| 0.699951
| 1.5
| 142
| null | 105
| 19
| null | null | null |
<2 mo. follow-up
| 2.198242
| 7
| 1
|
36.82397
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 7
|
under $11k
| 0
| 25,253
| 15,538.0781
| 15,734
| 17.5
|
white
| 22.5
| 47
| 0.865967
| 0.777954
| 1
| 0
| 0
|
no
| 0.6
| 0.45
|
no dnr
| 12
| 65
| 22.597656
| 60
| 10
| 38.29688
| 137.5
| 3
| 0.599976
| 1.5
| 136
| 7.489258
| 261
| 30
| 2,695
| 6
| 0
|
no(M2 and SIP pres)
| 0
| 808
| 0
|
51.16998
|
female
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 26,200
| 16,062
| 14,772
| 22.5
|
white
| 31.597656
| 51
| 0.512939
| 0.395996
| 2
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 13
| 69
| 3.399902
| 64
| 16
| 36.29688
| null | 2.699707
| null | 0.899902
| 124
| null | 78
| 11
| 1,750
| 1
| 1
|
SIP>=30
| 1
| 807
| 0
|
64.20496
|
female
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 0
| null | 0
| 32,290
| null | null | 22.5
|
black
| 29.699219
| 25
| 0.521973
| 0.405945
| 3
| 0
| 0
|
yes
| 0.9
| 0.85
|
no dnr
| 8
| 108
| 19.597656
| 65
| 8
| 36.19531
| 388
| null | 0.399963
| 8.298828
| 136
| 7.329102
| 146
| 54
| 835
| null | 1
| null | 1
| 807
| 0
|
50.76199
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 100
| 8,819
| 5,596.2266
| 4,756
| 20
|
black
| 52
| 53
| 0.001
| 0
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 58
| 16.199219
| 125
| 12
| 39.5
| 286.625
| null | null | 5.399414
| 133
| 7.40918
| 156
| 88
| 70
| null | null |
<2 mo. follow-up
| 3.615234
| 3
| 1
|
63.67398
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 27,389
| 15,589.3984
| 18,273
| 15
|
white
| 24.699219
| 24
| 0.776978
| 0.703979
| 3
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 10
| 83
| 7.599609
| 75
| 20
| 35.5
| null | null | null | 1.599854
| 141
| null | 97
| 13
| null | 0
| null |
no(M2 and SIP pres)
| 0.494751
| 806
| 0
|
68.58295
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 11
|
under $11k
| 0
| 10,106
| 5,244.6758
| 3,853
| 15
|
white
| 11.199219
| 5
| 0.800903
| 0.576904
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 4
| 72
| 9.199219
| 145
| 24
| 35.59375
| 309.5
| null | 1
| 1.599854
| 137
| 7.529297
| 157
| 41
| 1,730
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 806
| 0
|
79.58099
|
male
| 1
| 4
|
Coma
|
Coma
| 2
| null | null | 100
| 36,162
| 21,214.6406
| 19,782
| 35
|
white
| 60.398438
| 84
| 0
| 0
| 13
| 1
| 1
|
no
| 0.05
| 0.05
|
dnr after sadm
| 2
| 50
| 11
| 80
| 22
| 35.79688
| 264
| null | null | 3.099609
| 132
| 7.449219
| 104
| 52
| 770
| null | null |
<2 mo. follow-up
| 4.392578
| 4
| 1
|
83.58398
|
female
| 0
| 17
|
Coma
|
Coma
| 0
| 17
|
>$50k
| 44
| 73,879
| 43,665.25
| 45,931
| 13.666664
|
white
| 17.898438
| 34
| 0.366943
| 0.292969
| 14
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 3
| 73
| 5.599609
| 80
| 22
| 35.39844
| 239.125
| 3.399902
| null | 1.599854
| 137
| 7.389648
| 90
| 41
| 850
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 806
| 0
|
34.439
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 94
| null | null | null | 29.25
|
white
| 25.398438
| 28
| 0.55896
| 0.44696
| 3
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 25
| 75
| 10.898438
| 125
| 25
| 38.59375
| 438.0625
| null | 0.599976
| 3.5
| 137
| 7.329102
| 108
| 29
| 790
| null | 0
| null | 0
| 805
| 0
|
53.40198
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 9,731
| 5,429.5742
| 3,823
| 14
|
white
| 17.597656
| 5
| 0.723999
| 0.448975
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 4
| 60
| 10.398438
| 60
| 25
| 35.89844
| 362.8125
| 1.5
| 2.599609
| 5.299805
| 125
| 7.339844
| 206
| 72
| 94
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 102
| 1
|
44.81897
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 9
| null | 0
| 54,182
| 31,910.4219
| 30,886
| 31.666656
|
black
| 38
| 51
| 0.61499
| 0.509888
| 2
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 16
| 153
| 16.5
| 115
| 29
| 39.09375
| 283.3125
| null | 0.899902
| 0.799927
| 138
| 7.419922
| 173
| 8
| 4,400
| null | 1
|
no(M2 and SIP pres)
| 1
| 803
| 0
|
74.78699
|
male
| 1
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
| null | 0
| 35,324
| null | null | 33.5
|
white
| 23.398438
| 51
| 0.783936
| 0.653931
| 1
| 1
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 7
| 72
| 18.796875
| 125
| 32
| 36.59375
| 266.625
| 1.899902
| 1.299805
| 3.299805
| 136
| 7.469727
| 99
| 74
| 120
| 1
| null |
<2 mo. follow-up
| 1.166748
| 8
| 1
|
69.97894
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 27,063
| 16,028.375
| 20,265
| 28
|
white
| 25.5
| 40
| 0.641968
| 0.541992
| 3
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr before sadm
| -1
| 70
| 21.597656
| 105
| 24
| 35.89844
| null | null | 20.296875
| 2.599609
| 138
| null | 92
| 98
| 1,090
| null | 2
|
<2 mo. follow-up
| 2
| 6
| 1
|
25.254
|
female
| 0
| 73
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 0
| null | null | null | 45.5
|
black
| 45.5
| 71
| 0.522949
| 0.406982
| 3
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 24
| 122
| 6.799805
| 125
| 24
| 36.19531
| 280
| null | null | 1.399902
| 141
| 7.459961
| 95
| 18
| 3,430
| null | 0
|
no(M2 and SIP pres)
| 0
| 803
| 0
|
56.24597
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 0
| 107,025
| 59,218.7812
| 62,037
| 43
|
white
| 34.398438
| 80
| 0.562988
| 0.450989
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 75
| 13.398438
| 65
| 20
| 36
| null | 2.5
| 18.597656
| 2.099609
| 131
| null | 36
| 55
| 1,600
| null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
61.15298
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 8,201
| 4,998.1562
| 5,235
| 6
|
white
| 13.398438
| 10
| 0.865967
| 0.699951
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 100
| null | 75
| 26
| 36.59375
| 254.15625
| null | null | 0.799927
| 136
| 7.389648
| 148
| 21
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 240
| 1
|
69.42596
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 3
|
$11-$25k
| 37
| 37,687
| 24,268.3906
| 27,492
| 30
|
white
| 25.5
| 29
| 0.444946
| 0.325989
| 3
| 0
| 0
|
yes
| 0.05
| 0
|
no dnr
| 6
| 135
| 22.898438
| 65
| 35
| 36.5
| 200
| 2.799805
| 1.599854
| 6.299805
| 127
| 7.319336
| 91
| 68
| 36
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
49.30298
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 18,720
| 10,866.8438
| 11,675
| 28
|
white
| 34.398438
| 56
| 0.302979
| 0.190979
| 5
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 60
| 15.298828
| 125
| 10
| 38.19531
| 167.5
| null | null | 0.599976
| 135
| 7.429688
| 94
| 5
| 1,730
| null | null |
<2 mo. follow-up
| 2.436035
| 4
| 1
|
42.70499
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 95,884
| null | null | 20.333328
|
black
| 20.398438
| 18
| 0.870972
| 0.825928
| 10
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 19
| 125
| 9.5
| 115
| 9
| 38.5
| 164
| null | null | 1.099854
| 136
| 7.459961
| 174
| 26
| 3,335
| null | null |
adl>=4 (>=5 if sur)
| 2.511231
| 801
| 0
|
60.36697
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 15
|
>$50k
| 0
| 10,652
| null | null | 9
|
white
| 16.398438
| 10
| 0.72998
| 0.458984
| 1
| 0
| 0
|
metastatic
| 1
| 0.95
|
no dnr
| 6
| 113
| 4.899414
| 115
| 34
| 37.89844
| 215
| null | null | 0.899902
| 142
| 7.459961
| 118
| 13
| 3,480
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 109
| 1
|
59.51297
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 8,861
| 6,182.6094
| 5,707
| 14.5
|
white
| 21.199219
| 22
| 0.86499
| 0.775879
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 11
| 72
| 12
| 75
| 4
| 38.39844
| 215
| 2
| null | 1.399902
| 140
| 7.40918
| 128
| 26
| 2,605
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 801
| 0
|
81.52197
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 15
| null | 0
| 9,687
| 5,528.4688
| 4,374
| 11
|
black
| 19.199219
| 12
| 0.747925
| 0.487976
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 108
| 12.199219
| 115
| 9
| 38.59375
| 157.5
| null | null | 4.299805
| 149
| 7.509766
| 233
| 81
| 3,095
| 4
| 3
|
no(M2 and SIP pres)
| 3
| 118
| 1
|
60.65698
|
male
| 0
| 27
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 4
| null | 0
| 116,117
| 66,416
| 60,614
| 25.5
|
white
| 23.5
| 32
| 0.695923
| 0.530884
| 3
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 27
| 85
| 4.699219
| 65
| 22
| 36.5
| null | 3.699707
| 0.699951
| 1.5
| 140
| null | 85
| 8
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 801
| 0
|
57.53897
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 4,855
| 3,390.8594
| 3,726
| 14
|
white
| 24.199219
| 26
| 0.562988
| 0.240997
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.6
|
no dnr
| 4
| 58
| 14.599609
| 65
| 26
| 38.39844
| 400
| null | null | 0.699951
| 142
| 7.389648
| 141
| 9
| 3,220
| null | 4
|
<2 mo. follow-up
| 4
| 29
| 1
|
36.84097
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 41
| null | 28,480.3594
| 27,868
| 44
|
black
| 29.5
| 59
| 0.704956
| 0.615967
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 12
| 118
| 14.199219
| 105
| 26
| 38.59375
| 284
| null | 0.899902
| 0.599976
| 141
| 7.439453
| 101
| 3
| 4,340
| null | null |
no(M2 and SIP pres)
| 2.710449
| 798
| 0
|
67.49896
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 7,342
| 4,205.8242
| 2,525
| 13
|
white
| 19.898438
| 11
| 0.768921
| 0.521973
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 6
| 113
| 5.299805
| 68
| 20
| 36.5
| null | 3.699707
| 0.5
| 10.398438
| 138
| null | 72
| 45
| null | 0
| 0
| null | 0
| 250
| 1
|
61.06497
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 20
| null | 0
| 19,506
| 11,892.625
| 11,220
| 17
|
white
| 17.199219
| 26
| 0.712891
| 0.432983
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 10
| 112
| 6.5
| 125
| 28
| 35.89844
| 110.20312
| null | null | 0.5
| 138
| 7.509766
| 145
| 21
| 3,535
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 798
| 0
|
61.65097
|
male
| 1
| 16
|
Coma
|
Coma
| 4
| 12
| null | 61
| 44,669
| 26,613.8281
| 26,918
| 29.333328
|
black
| 20
| 32
| 0.552979
| 0.484985
| 1
| 1
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 1
| 71
| 7.099609
| 74
| 16
| 35.79688
| null | null | 0.399963
| 0.799927
| 139
| null | 114
| 12
| 2,050
| null | 3
|
<2 mo. follow-up
| 3
| 16
| 1
|
49.125
|
female
| 1
| 60
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 9
| null | 197,475.75
| 185,879
| 52
|
white
| 30.796875
| 52
| 0.407959
| 0.287964
| 2
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 45
| 72
| 4.799805
| 45
| 20
| 36.29688
| null | 3.899902
| 0.5
| 1.099854
| 139
| null | 104
| 7
| null | null | 1
| null | 1
| 60
| 1
|
48.67899
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 8,753
| 5,985.1289
| 5,681
| 13
|
white
| 21
| 24
| 0.893921
| 0.821899
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 8
| 119
| 7
| 128
| 32
| 36.39844
| null | null | null | 0.899902
| 139
| null | 118
| 8
| null | 0
| 0
|
SIP>=30
| 0
| 797
| 0
|
71.90997
|
male
| 0
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 3
|
under $11k
| 0
| 58,249
| null | null | 22
|
other
| 26.097656
| 38
| 0.487976
| 0.369995
| 7
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 22
| 77
| 16.199219
| 115
| 6
| 39.39844
| 252.5
| null | null | 0.899902
| 143
| 7.569336
| 176
| 14
| 1,980
| null | 7
|
no(M2 and SIP pres)
| 7
| 318
| 1
|
49.21799
|
male
| 1
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 44
| 37,986
| 23,976.9844
| 27,007
| 26
|
white
| 36.09375
| 82
| 0.30896
| 0.128998
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 150
| 19.097656
| 140
| 40
| 38.79688
| 187.5
| null | null | 2
| 142
| 7.5
| 158
| 113
| 2,950
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
56.36697
|
male
| 1
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 15,479
| 8,717.2109
| 8,650
| 36
|
white
| 32.695313
| 48
| 0.708984
| 0.54895
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 103
| 9.5
| 65
| 28
| 38.19531
| 148.96875
| null | null | 1.199951
| 141
| 7.429688
| 118
| 23
| 925
| 0
| 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
73.85394
|
female
| 1
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 37
| 156,015
| 88,125.1875
| 82,866
| 43.25
|
black
| 28.097656
| 37
| 0.521973
| 0.405945
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 16
| 103
| 7.5
| 80
| 20
| 36.29688
| null | 3
| 3.5
| 1
| 133
| null | 105
| 10
| 2,075
| null | null |
<2 mo. follow-up
| 2.564941
| 31
| 1
|
66.63098
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 50,995
| null | null | 25
|
white
| 26.296875
| 22
| 0.766968
| 0.691895
| 1
| 0
| 0
|
no
| 0.3
| 0.2
|
no dnr
| 17
| 60
| 20.5
| 100
| 9
| 37
| 180
| 2.599609
| null | 1.099854
| 145
| 7.459961
| 206
| 42
| 1,545
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 796
| 0
|
67.46295
|
female
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 7
| null | 0
| 62,389
| null | null | 17.666656
|
white
| 19.398438
| 17
| 0.860962
| 0.769897
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 19
| 73
| 15.798828
| 75
| 28
| 36
| 200
| 4.099609
| 0.699951
| 0.699951
| 140
| 7.389648
| 281
| 5
| 1,800
| 5
| null | null | 3.854981
| 70
| 1
|
22.63699
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 172,064
| 103,872.812
| 124,299
| 26
|
black
| 23.699219
| 36
| 0.896973
| 0.859985
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 42
| 38
| 14.099609
| 95
| 12
| 35.09375
| 197.5
| 1.899902
| 1
| 3.199707
| 129
| 7.449219
| 244
| 31
| 0
| null | 0
| null | 0
| 795
| 0
|
58.52197
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| null | 8,245.4297
| 9,055
| 15
|
white
| 17
| 20
| 0.903931
| 0.837891
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 10
| 82
| 9.298828
| 112
| 20
| 36.39844
| null | 2.699707
| 2.899902
| 1
| 127
| null | 114
| 31
| 1,900
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 65
| 1
|
69.45099
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 0
| 45,707
| 26,465.7188
| 29,656
| 22.666656
|
black
| 22.898438
| 16
| 0.783936
| 0.713989
| 3
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 5
| 147
| 10.699219
| 115
| 25
| 38.5
| 393.3125
| null | null | 0.799927
| 133
| 7.439453
| 161
| 16
| 2,305
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 81
| 1
|
71.18695
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 69,569
| 40,665.0312
| 37,001
| 25
|
black
| 32
| 96
| 0.295959
| 0.184998
| 18
| 0
| 0
|
no
| 0.03
| 0.01
|
dnr after sadm
| 2
| 67
| 10
| 119
| 26
| 37.69531
| null | 2.099609
| 0.899902
| 0.399963
| 134
| null | 174
| 3
| null | null | null |
<2 mo. follow-up
| 2.80957
| 4
| 1
|
44.44098
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 5,385
| 3,102.6836
| 3,011
| 10
|
black
| 29.5
| 44
| 0.727905
| 0.574951
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 102
| 14
| 45
| 12
| 38.29688
| 344
| null | null | 0.899902
| 132
| 7.439453
| 189
| 13
| 2,135
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 96
| 1
|
61.36099
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 15
|
>$50k
| 0
| 9,995
| 5,151.3203
| 2,624
| 13
|
white
| 20.796875
| 3
| 0.767944
| 0.518921
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 5
| 125
| 3.799805
| 60
| 28
| 35.29688
| 266.625
| 2.699707
| null | 0.799927
| 137
| 7.449219
| 285
| 13
| 1,955
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 465
| 1
|
71.99695
|
male
| 0
| 89
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 207,723
| 127,257.875
| 130,479
| 32.75
|
black
| 21.5
| 36
| 0.746948
| 0.667969
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 89
| 100
| 8.5
| 75
| 18
| 36.5
| 256.5
| 4.099609
| 0.399963
| 1
| 139
| 7.40918
| 79
| 13
| 900
| null | 6
| null | 6
| 222
| 1
|
57.70599
|
male
| 0
| 50
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 0
| 191,559
| 118,099.75
| 133,797
| 14.75
|
white
| 29.5
| 54
| 0.670898
| 0.575928
| 14
| 0
| 0
|
no
| null | null |
no dnr
| 50
| 53
| 16.296875
| 105
| 10
| 37.79688
| 165
| 1.799805
| null | 0.5
| 129
| 7.479492
| 213
| 18
| 3,900
| 2
| 2
|
no(M2 and SIP pres)
| 2
| 130
| 1
|
57.34198
|
male
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 42,913
| 25,772.3906
| 25,675
| 19.333328
|
black
| 23.199219
| 33
| 0.86499
| 0.776978
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 18
| 68
| 11.099609
| 145
| 9
| 35
| 220
| null | 0.799927
| 2.399902
| 129
| 7.349609
| 192
| 55
| 2,230
| null | 0
|
no(M2 and SIP pres)
| 0
| 790
| 0
|
50.89398
|
female
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| null | 18,112
| 18,462
| 21.5
|
white
| 22.199219
| 36
| 0.67395
| 0.577881
| 2
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 9
| 75
| 7.799805
| 75
| 32
| 35.89844
| 226.65625
| 2.699707
| 1.899902
| 1.299805
| 141
| 7.339844
| 126
| 48
| 1,550
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 74
| 1
|
64.70398
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 2
| 16
| null | 0
| 20,581
| null | null | 7
|
white
| 15.298828
| 5
| 0.838989
| 0.647949
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 4
| 62
| 7.799805
| 65
| 28
| 36
| null | null | null | 1.799805
| 132
| null | 155
| 45
| 2,390
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 789
| 0
|
84.862
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 44
| 34,260
| null | null | 19.5
|
white
| 31.699219
| 58
| 0.222992
| 0.125
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 100
| 17.699219
| 120
| 30
| 38.29688
| 310
| 2
| 2.699707
| 1.399902
| 139
| 7.419922
| 121
| 48
| 2,330
| null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
70.77594
|
female
| 1
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 44
| 94,253
| 56,570.1562
| 61,229
| 59.5
|
white
| 49
| 87
| 0.001
| 0
| 16
| 1
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 9
| 62
| 2.5
| 125
| 33
| 37.79688
| 404
| 2.599609
| 1.699951
| 2.199707
| 149
| 7.40918
| 74
| 25
| 1,550
| null | 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
55.30698
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
| null | 0
| 45,838
| null | null | 23
|
black
| 18.199219
| 17
| 0.906982
| 0.843994
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 16
| 122
| 6
| 125
| 26
| 36.19531
| 185.6875
| null | null | 0.699951
| 130
| 7.439453
| 126
| 7
| 2,035
| null | 0
|
no(M2 and SIP pres)
| 0
| 788
| 0
|
70.74896
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 153,838
| 86,810.3125
| 86,737
| 40.25
|
white
| 32.398438
| 56
| 0.621948
| 0.517944
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 42
| 48
| 1.799805
| 0
| 24
| 36.09375
| 142.5
| null | null | 0.599976
| 128
| 7.429688
| 36
| 18
| 3,180
| null | null | null | 2.522461
| 788
| 0
|
84.474
|
female
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 2,348
| 1,736.6465
| 1,974
| 9
|
white
| 19.5
| 34
| 0.802979
| 0.681885
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 73
| 4.399414
| 64
| 32
| 38.39844
| 138.3125
| null | null | 0.899902
| 134
| 7.449219
| 210
| 15
| 1,940
| null | null |
<2 mo. follow-up
| 2.685547
| 4
| 1
|
53.29999
|
female
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| 10
|
under $11k
| 0
| 16,419
| null | null | 7.333332
|
hispanic
| 28.296875
| 44
| 0.685913
| 0.517944
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 97
| 5.199219
| 70
| 20
| 37
| null | 3.699707
| 0.599976
| 0.899902
| 140
| null | 98
| 6
| 3,400
| 0
| 6
|
<2 mo. follow-up
| 6
| 19
| 1
|
45.26797
|
male
| 1
| 31
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
under $11k
| 44
| 88,046
| 56,097.2188
| 64,470
| 26.75
|
black
| 44.59375
| 84
| 0.018997
| 0.004
| 5
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 3
| 20
| 12.298828
| 0
| 0
| 37.79688
| 154
| 3.399902
| 0.799927
| 1.5
| 135
| 7.40918
| 255
| 31
| 1,310
| null | 0
|
<2 mo. follow-up
| 0
| 31
| 1
|
70.88599
|
female
| 0
| 31
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 91,599
| 53,839.2812
| 57,139
| 25.25
|
white
| 21.796875
| 34
| 0.636963
| 0.534912
| 3
| 1
| 0
|
metastatic
| 0.95
| 0.9
|
no dnr
| 31
| 78
| 14
| 65
| 26
| 37.59375
| null | null | null | 0.699951
| 137
| null | 365
| 30
| 1,280
| null | 0
|
<2 mo. follow-up
| 0
| 46
| 1
|
75.90094
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 3,281
| 2,380.8574
| 2,666
| 9
|
white
| 21.898438
| 31
| 0.800903
| 0.678955
| 1
| 1
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 4
| 112
| 11.798828
| 45
| 35
| 39
| 188.5625
| null | null | 0.799927
| 133
| 7.399414
| 148
| 14
| 3,950
| null | null |
SIP>=30
| 2.245606
| 645
| 1
|
58.58197
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 9
| 62,225
| 34,993.1562
| 37,089
| 31.666656
|
black
| 35.695313
| 78
| 0.546997
| 0.43396
| 2
| 1
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 18
| 80
| 13
| 72
| 20
| 36.89844
| null | 3.299805
| 0.599976
| 0.799927
| 138
| null | 171
| 3
| 2,500
| null | 0
|
no(M2 and SIP pres)
| 0
| 786
| 0
|
76.12299
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 81,539
| 46,428
| 46,704
| 42.5
|
white
| 33.398438
| 52
| 0.366943
| 0.248993
| 16
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 2
| 45
| 11.398438
| 145
| 41
| 38.19531
| 151.40625
| 2.699707
| 1.399902
| 0.699951
| 139
| 7.05957
| 68
| 7
| 2,005
| null | null |
<2 mo. follow-up
| 2.240723
| 7
| 1
|
56.89798
|
female
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 167,108
| null | null | 33.75
|
white
| 27.296875
| 46
| 0.741943
| 0.660889
| 6
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 39
| 65
| 6.899414
| 70
| 26
| 37.79688
| 352
| null | null | 4.299805
| 131
| 7.519531
| 237
| 94
| 585
| null | 0
| null | 0
| 786
| 0
|
79.31799
|
male
| 0
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 44
| null | 205,665.625
| 192,444
| 38.25
|
white
| 37.398438
| 68
| 0.134979
| 0.061996
| 1
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 57
| 128
| 19.296875
| 160
| 14
| 35.09375
| 330
| null | null | 1
| 136
| 7.40918
| 138
| 26
| 1,700
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 104
| 1
|
49.10599
|
female
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 147,854
| 81,525.25
| 88,502
| 31.75
|
black
| 29.296875
| 44
| 0.769897
| 0.695923
| 2
| 0
| 0
|
no
| 0.7
| 0.65
|
no dnr
| 34
| 48
| 15.298828
| 145
| 15
| 39
| 140
| 2.5
| 4
| 3.599609
| 131
| 7.399414
| 103
| 23
| 1,600
| null | 0
|
no(M2 and SIP pres)
| 0
| 783
| 0
|
49.28098
|
male
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 100
| 17,741
| null | null | 15.5
|
white
| 35
| 53
| 0.089996
| 0.014999
| 1
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 1
| 58
| 19.097656
| 190
| 47
| 37.69531
| 176
| 2.199707
| 11.298828
| 0.799927
| 143
| 7.449219
| 234
| 7
| 7,790
| null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
77.17999
|
female
| 0
| 88
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 26
| null | 412,953
| 427,935
| 34.25
|
white
| 36.5
| 79
| 0.197998
| 0.105988
| 86
| 1
| 0
|
no
| 0.2
| 0.5
|
no dnr
| 88
| 112
| 9.5
| 65
| 20
| 37.79688
| null | null | 0.599976
| 1
| 137
| null | 117
| 12
| 1,880
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 264
| 1
|
51.504
|
female
| 0
| 22
|
Coma
|
Coma
| 1
| 11
|
$25-$50k
| 9
| 52,590
| null | null | 30.666656
|
white
| 17.699219
| 8
| 0.827881
| 0.792969
| 2
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 22
| 108
| 78.1875
| 105
| 10
| 37.79688
| 167.34375
| null | 1.199951
| 0.899902
| 149
| 7.349609
| 99
| 22
| 2,170
| null | 0
|
no(M2 and SIP pres)
| 0
| 782
| 0
|
65.56598
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 57,122
| 33,227.5938
| 32,585
| 29
|
white
| 30.699219
| 60
| 0.621948
| 0.517944
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 18
| 72
| 22.898438
| 125
| 13
| 37.89844
| 164
| null | null | 2.899902
| 130
| 7.349609
| 124
| 58
| 1,066
| null | 7
|
SIP>=30
| 7
| 452
| 1
|
64.66498
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
$11-$25k
| 0
| null | 21,407.9375
| 27,319
| 17
|
white
| 17.398438
| 36
| 0.882935
| 0.840942
| 1
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 15
| 93
| 14.898438
| 75
| 30
| 36.39844
| 305
| 3.099609
| 1.899902
| 0.899902
| 132
| 7.429688
| 150
| 30
| 3,685
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 781
| 0
|
75.77295
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
>$50k
| 0
| 226,055
| 124,220.188
| 123,581
| 28.333328
|
white
| 27.796875
| 47
| 0.593994
| 0.485962
| 32
| 0
| 0
|
no
| 0.65
| 0.6
|
no dnr
| 23
| 117
| 6.5
| 100
| 20
| 36.29688
| null | null | 0.599976
| 1
| 138
| null | 103
| 15
| null | null | 5
|
SIP>=30
| 5
| 781
| 0
|
71.19495
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 38,463
| 23,534.8594
| 25,944
| 32
|
white
| 47.5
| 74
| 0.196991
| 0.104996
| 1
| 0
| 0
|
no
| 0.4
| 0.4
|
dnr after sadm
| 3
| 80
| 8.298828
| 109
| 22
| 36.19531
| null | null | 2.199707
| 1.5
| 138
| null | 82
| 27
| 2,800
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
37.83698
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 46,743
| null | null | 20
|
asian
| 21.796875
| 26
| 0.668945
| 0.572998
| 5
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 79
| 7.199219
| 72
| 20
| 38.69531
| null | 2.899902
| 0.599976
| 0.899902
| 141
| null | 97
| 5
| 4,700
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 780
| 0
|
47.13498
|
male
| 0
| 26
|
Coma
|
Coma
| 0
| 17
|
$11-$25k
| 44
| 72,007
| 45,311.5312
| 47,142
| 23
|
white
| 22.398438
| 22
| 0.626953
| 0.564941
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 26
| 112
| 18.199219
| 135
| 33
| 38.39844
| 243.3125
| 2
| 1.299805
| 0.599976
| 145
| 7.419922
| 118
| 15
| 1,705
| null | 0
|
no(M2 and SIP pres)
| 0
| 780
| 0
|
70.49097
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| null | 13,936.1016
| 16,877
| 39
|
white
| 44.898438
| 82
| 0.273987
| 0.165985
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 71
| 3.099609
| 113
| 28
| 35.09375
| null | null | null | 1.299805
| 135
| null | 107
| 18
| null | null | null |
<2 mo. follow-up
| 1.950439
| 3
| 1
|
69.42896
|
female
| 0
| 122
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 0
| 367,125
| 220,730.75
| 206,405
| 39.5
|
black
| 35.796875
| 79
| 0.544922
| 0.430969
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 122
| 147
| 7.799805
| 120
| 6
| 36.09375
| 253.3125
| 2.399902
| 3.899902
| 4.099609
| 147
| 7.399414
| 177
| 54
| 820
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 253
| 1
|
65.54999
|
male
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 219,969
| 114,773.188
| 124,871
| 44.666657
|
white
| 38.195313
| 60
| 0.290955
| 0.181
| 20
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 18
| 106
| 10.398438
| 55
| 16
| 35.59375
| null | 3.399902
| 0.5
| 1.099854
| 140
| null | 191
| 14
| 3,650
| null | null |
<2 mo. follow-up
| 2.347168
| 24
| 1
|
58.66098
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 10
|
under $11k
| 0
| 3,723
| null | null | 8
|
black
| 20.699219
| 43
| 0.883911
| 0.806885
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 4
| 65
| 11.599609
| 105
| 14
| 38.19531
| 312
| null | null | 1
| 135
| 7.359375
| 144
| 21
| 1,260
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 778
| 0
|
61.82898
|
female
| 1
| 30
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 21
|
>$50k
| 0
| 43,942
| 27,844.7969
| 28,191
| 17.25
|
white
| 27.699219
| 64
| 0.73291
| 0.580933
| 1
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 9
| 118
| 14.699219
| 75
| 10
| 35.89844
| 253.3125
| null | 3
| 1.199951
| 147
| 7.489258
| 239
| 18
| 930
| null | 2
|
<2 mo. follow-up
| 2
| 30
| 1
|
77.01294
|
female
| 0
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 177,611
| 102,840.75
| 100,930
| 44.25
|
white
| 31
| 52
| 0.620972
| 0.515991
| 1
| 0
| 0
|
no
| 0.5
| 0.125
|
no dnr
| 57
| 65
| 10.5
| 120
| 12
| 37.79688
| 178
| 2.799805
| 3.599609
| 2.599609
| 149
| 7.389648
| 74
| 26
| 710
| null | 0
|
SIP>=30
| 0
| 776
| 0
|
64.586
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 9
| 53,737
| 30,612.4062
| 34,432
| 26.333328
|
white
| 18.699219
| 27
| 0.843994
| 0.790894
| 2
| 0
| 0
|
no
| 0.4
| 0.35
|
no dnr
| 16
| 98
| 15.398438
| 75
| 24
| 36.69531
| 271.375
| null | 0.699951
| 2.899902
| 138
| 7.289062
| 182
| 59
| null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 197
| 1
|
69.20197
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 9
| 66,688
| 43,376.4688
| 49,564
| 13
|
white
| 25.296875
| 27
| 0.651978
| 0.552979
| 35
| 0
| 0
|
no
| 0.9
| 0.88
|
no dnr
| 22
| 108
| 1
| 110
| 33
| 38.09375
| 230
| 2.599609
| 0.699951
| 0.899902
| 145
| 7.539062
| 99
| 27
| 2,375
| 7
| 7
|
adl>=4 (>=5 if sur)
| 7
| 775
| 0
|
63.28299
|
male
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 23,392
| null | null | 18.666656
|
white
| 12.298828
| 12
| 0.872925
| 0.713989
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 17
| 55
| 28
| 70
| 30
| 36.09375
| 214.28125
| 1
| 18.199219
| 8
| 136
| 7.389648
| 84
| 101
| 940
| null | 0
| null | 0
| 82
| 1
|
70.04797
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 0
| 56,994
| 33,252.2812
| 35,871
| 43.5
|
white
| 20.097656
| 18
| 0.842896
| 0.78894
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 13
| 42
| 4.899414
| 75
| 11
| 37.59375
| 324
| null | null | 1.599854
| 127
| 7.479492
| 210
| 49
| 3,955
| null | 1
|
no(M2 and SIP pres)
| 1
| 122
| 1
|
59.32599
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 11,088
| null | null | 16
|
white
| 25.296875
| 22
| 0.831909
| 0.725952
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 6
| 48
| 22.097656
| 115
| 8
| 38.69531
| 220
| 2.299805
| 0.699951
| 1.399902
| 144
| 7.429688
| 227
| 18
| 3,620
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 196
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.